Fresenius Medical Care AG

FME

DE0005785802

Healthcare Facilities & Services

Market Closed - Xetra Other stock markets 16:39:57 16/06/2025 BST			5-day change	1st Jan Change
49.49 ^EUR	-0.78%		-1.65%	+12.07%

06-09	AlphaValue/Baader Europe Updates Fresenius Medical Rating; EPS Estimates Upgraded	MT
06-06	DAX Index Edges Down Amid Downbeat German Trade, Industrial Data	MT

Fresenius Signs Agreements With Wind, Solar Energy Project Developers in US, Germany

Published on 12/06/2024 at 14:09, updated on 12/06/2024 at 14:12

This article is reserved for members

Unlock the article: REGISTER NOW!

100% Free Registration

Already a customer? Log In

Latest news about Fresenius Medical Care AG

AlphaValue/Baader Europe Updates Fresenius Medical Rating; EPS Estimates Upgraded	06-09	MT
DAX Index Edges Down Amid Downbeat German Trade, Industrial Data	06-06	MT
FRESENIUS MEDICAL CARE : Nearing our targets	06-06
FMC FRESENIUS MEDICAL CARE AG : JP Morgan remains a Sell rating	06-06	ZD
Tariffs come and go	05-30
FMC FRESENIUS MEDICAL CARE AG : Gets a Sell rating from Jefferies	05-30	ZD
FMC FRESENIUS MEDICAL CARE AG : UBS sticks Neutral	05-26	ZD
DAX Expected to Open Lower as Investors Eye Ifo Index	05-22	RE
Goldman raises target for FMC to €60 – 'Buy'	05-21	DP
FMC FRESENIUS MEDICAL CARE AG : Goldman Sachs keeps its Buy rating	05-21	ZD
Fresenius Expands Its Line Of Epinephrine Injectables In The U.S.	05-20	RE
FMC FRESENIUS MEDICAL CARE AG : Barclays reiterates its Neutral rating	05-20	ZD
FMC FRESENIUS MEDICAL CARE AG : JP Morgan remains a Sell rating	05-14	ZD
FMC FRESENIUS MEDICAL CARE AG : Gets a Buy rating from DZ Bank	05-12	ZD
FMC FRESENIUS MEDICAL CARE AG : Gets a Neutral rating from Barclays	05-08	ZD
Deutsche Bank Says Fresenius Remains 'Top Pick' After Q1 Beat	05-08	MT
Strong quarterly figures push Fresenius to three-year high	05-07	DP
Fresenius makes progress with restructuring and earns surprisingly high profits	05-07	DP
Fresenius: in the black after its quarterly results	05-07	CF
Deutsche Bank Maintains Investment Decision on Fresenius Medical Post Upbeat Q1 Earnings	05-07	MT
FMC FRESENIUS MEDICAL CARE AG : JP Morgan gives a Sell rating	05-07	ZD
FMC FRESENIUS MEDICAL CARE AG : Receives a Buy rating from Goldman Sachs	05-07	ZD
Fresenius Boosts Operating Profit - 2025 Outlook Confirmed	05-07	RE
FMC FRESENIUS MEDICAL CARE AG : Berenberg reiterates its Buy rating	05-07	ZD
Fresenius posts profit beat in first quarter, confirms outlook	05-07	RE

Chart Fresenius Medical Care AG

Duration

Period

FME: Dynamic Chart

Fresenius Medical Care AG is the world's leading supplier of services and equipment for patients with kidney problems. Net sales break down by activity as follows: - clinical care services (78%): operated, at the end of 2024, 3,675 institutions; - manufacturing of dialyzers and related products (22%): hemo-dialysis and pediatric dialysis machines, etc. The group also offers therapies accompanied by care and treatment for dialysis patients. Net sales are distributed geographically as follows: Germany (2.5%), the United States (70.7%) and other (26.8%).

Employees

112,035

Sector

Healthcare Facilities & Services

Calendar

10:00am - Capital Markets Day

More about the company